Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis* B.J. Holzknecht, J. Thorup, M.C. Arendrup, S.E.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

L. Boyanova Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz

Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection

Migrant health—a cause for concern?

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

J. M. Pereira, R. P. Moreno, R. Matos, A. Rhodes, I. Martin-Loeches, M

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis G. Choudhury,

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Candida glabrata fungaemia in intensive care units

J.-P. Van geertruyden Clinical Microbiology and Infection

The microarray technology: facts and controversies

U.S. Jensen, J.D. Knudsen, S. Wehberg, D.B. Gregson, K.B. Laupland

R. Cantón Clinical Microbiology and Infection

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Semi-national surveillance of fungaemia in Denmark 2004–2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia D. Kese, M. Maticic, M. Potocnik Clinical.

Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic A.S.

Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.

Surveillance of Legionnaires’ disease in Austria

Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study J. Gonçalves-Pereira,

Vector control: a cornerstone in the malaria elimination campaign

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

G. Höffken Clinical Microbiology and Infection

A. Pan, R. Buttazzi, M. Marchi, C. Gagliotti, D. Resi, M.L. Moro

B. J. Kullberg, P. E. Verweij, M. Akova, M. C. Arendrup, J. Bille, T

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Levofloxacin in the treatment of ventilator-associated pneumonia

Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose P. Savard, T.M. Perl Clinical Microbiology.

Metagenomics and probiotics

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10- year period ( ) M. Cuttelod, L. Senn, V. Terletskiy, I. Nahimana,

Systematic review of antibiotic consumption in acute care hospitals

Update on antifungal resistance in Aspergillus and Candida

R. Luzzati, B. Allegranzi, L. Antozzi, L. Masala, E. Pegoraro, A

Eleven-year retrospective survey of candidaemia in a university hospital in southwestern Greece A. Spiliopoulou, S. Vamvakopoulou, C. Bartzavali, G.

M. Bassetti, M.P. Molinari, M. Mussap, C. Viscoli, E. Righi

Abstracts cont. Clinical Microbiology and Infection

Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital R. Herruzo, F.

Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance.

Evolution and aetiological shift of catheter-related bloodstream infection in a whole institution: the microbiology department may act as a watchtower

V. Spoorenberg, J. M. Prins, B. C. Opmeer, T. M. de Reijke, M. E. J. L

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

Easily available adjustment criteria for the comparison of antibiotic consumption in a hospital setting: experience in France B. Amadeo, C. Dumartin,

An after-hours clinical liaison blood culture service—is it worth it?

Statin use and clinical outcomes among pneumonia patients

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Overview of cefixime use in community-acquired infections

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia U. Hohenthal, S. Hurme, H. Helenius,

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection A. Russo, M. Falcone, M. Fantoni, R. Murri,

Presentation transcript:

Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis* B.J. Holzknecht, J. Thorup, M.C. Arendrup, S.E. Andersen, M. Steensen, P. Hesselfeldt, J.M. Nielsen, J.D. Knudsen Clinical Microbiology and Infection Volume 17, Issue 9, Pages 1372-1380 (September 2011) DOI: 10.1111/j.1469-0691.2010.03422.x Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Quarterly numbers of candidaemia patients, episodes of blood stream infections, admissions, surgical procedures and fluconazole consumption. Patients with candidaemia, BSI episodes and admissions in ICUs include only abdominal surgery patients. Fluconazole consumption in ICUs was calculated for all patients. Q, quartal; BSI, blood stream infection; ICU, intensive care unit; DDD, defined daily doses. Clinical Microbiology and Infection 2011 17, 1372-1380DOI: (10.1111/j.1469-0691.2010.03422.x) Copyright © 2011 European Society of Clinical Infectious Diseases Terms and Conditions